-
Mashup Score: 0
Veeral Sheth, MD, is joined by the director of marketing of eSight to discuss the 5th generation eSight Go, a device to enhance central vision functions in patients with a variety of eye diseases.
Source: www.hcplive.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
New data from a UMichigan survey found that 8% of preventative aspirin users had not even discussed their use with any health care provider.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
New research has found that a significant portion of older adults use aspirin for primary prevention without physician consultation, highlighting under-recognized bleeding risk concerns. Learn more: https://t.co/pPH3dkDLtR https://t.co/0d8YRf121t
-
-
Mashup Score: 0
The prespecified analysis of FINEARTS-HF found finerenone’s impact on HF events, cardiovascular death, and symptoms was not impacted by frailty.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
Findings from a prespecified analysis of FINEARTS-HF suggest finerenone maintains benefits for reducing the risk of total worsening heart failure events and cardiovascular death as well as symptom improvement in patients with #frailty. Learn more: https://t.co/O4Q7aUNgqn https://t.co/dQ9lTckfjj
-
-
Mashup Score: 2
This announcement highlights Pelthos Therapeutics’ launch of berdazimer (ZELSUVMI) topical gel 10.3% for molluscum contagiosum.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
Berdazimer topical gel, 10.3% (ZELSUVMI) is the first FDA-approved at-home treatment for #MolluscumContagiosum, offering an option for patients aged 1+ years. View more: https://t.co/Dd6uAKuT6q
-
-
Mashup Score: 3No Long-Term Dementia Risk Linked to Transient Ischemic Attack, 20-Year Study Finds - 11 hour(s) ago
Contrary to earlier research, a Framingham Heart Study analysis found no significant dementia risk tied to transient ischemic attack over 2 decades.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
A 20-year study found no significant link between transient ischemic attack and long-term #dementia risk. Vascular risk factor changes, like more anticoagulant use, may play a role. https://t.co/0IBXx9KDL3 #Stroke
-
-
Mashup Score: 0No Long-Term Dementia Risk Linked to Transient Ischemic Attack, 20-Year Study Finds - 13 hour(s) ago
Contrary to earlier research, a Framingham Heart Study analysis found no significant dementia risk tied to transient ischemic attack over 2 decades.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
A 20-year study found no significant link between transient ischemic attack and long-term #dementia risk. Vascular risk factor changes, like more anticoagulant use, may play a role. https://t.co/rZ5eVZRZVC #Stroke
-
-
Mashup Score: 3Artificial Intelligence in Cataract Surgery and Optometry at Large with Harvey Richman, OD, and Rebecca Wartman, OD - 20 hour(s) ago
Drs. Richman and Wartman discuss the benefits of using predictive and diagnostic AI, while cautioning about the implicit risks of overreliance on early, imperfect technology.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
At #AOA25, we sat down with Harvey Richman, OD, and Rebecca Wartman, OD, to discuss their presentation on #AI and its use in cataract surgery. Watch the full video here: https://t.co/u35PN8vttr https://t.co/1EbvS65GUO
-
-
Mashup Score: 6Nephrology First Half Recap: 2025 - 21 hour(s) ago
The first half of 2025 recap for nephrology spotlights renal FDA action, ERA 2025 Congress coverage, and updates in xenotransplantation.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
From FDA approvals to new clinical trial data and progress in xenotransplantation, the first half of 2025 was full of innovations in #nephrology. Check out our recap for a full breakdown of what shaped the first 6 months of the year: https://t.co/juaxdqsMIz https://t.co/Ed00APQnpH
-
-
Mashup Score: 2Advancing Treatment for C3G; Targeting the Complement System for Personalized Kidney Care - 23 hour(s) ago
Sayna Norouzi, MD; Jonathan Barratt, MBChB, PhD, FRCP; Andrew S. Bomback, MD, MPH; Bradley Dixon, MD; and Brendon Neuen, MD, discuss how the diagnostic challenges of C3 glomerulopathy (C3G) are addressed, current treatment strategies are explored, and emerging therapies, including insights from the VALIANT trial, may impact clinical practice.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
C3G is complex—and evolving. Experts discuss diagnostic challenges, current treatments, and emerging therapies like the VALIANT trial in our latest HCPLive® video series. Watch now to deepen your understanding. https://t.co/WzSNsAa0uG #C3G #Nephrology #HCPLive https://t.co/jS01xjRG41
-
-
Mashup Score: 2Skin of Color Savvy: UV Safety in Skin of Color, with Rebecca Vasquez, MD and Adewole Adamson, MD, MPP - 23 hour(s) ago
This clinical episode of Skin of Color Savvy features a discussion on UV safety and photo protection in patients with skin of color.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
A NEW Skin of Color Savvy🎙️ podcast is out today! This podcast, by @SkinOfColor and HCPLive, included Drs. Rebecca Vasquez (@UTSWDerm) & Adewole Adamson (@DellMedSchool). They discuss an important topic:☀️UV safety in skin of color. View here: https://t.co/55E2yU02bR https://t.co/hhcXafRBVW
-
Check out the latest episode of #NewInsight, where Veeral Sheth, MD, and Roland Mattern, director of marketing at eSight, discuss the eSight Go visual aid device and how it can help those with visual impairments return to everyday life! Watch now: https://t.co/mYgF6TezFS https://t.co/efUiblwYiW